Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
eculizumab complement c5 biotech NA drugbank , DGIDB Paroxysmal nocturnal hemoglobinuria[MeSHID:D006457]
Atypical Hemolytic Uremic Syndrome[MeSHID:D065766]
Neuromyelitis Optica[MeSHID:D009471]
Hemolysis (disorder)[MeSHID:D006461]
Cardiac Arrest[MeSHID:D006323]
Thrombotic Microangiopathies[MeSHID:D057049]
Macular Degeneration
Age-Related
2[MeSHID:C562479]
Age related macular degeneration[MeSHID:D008268]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 45.47 approved,investigational antibody,inhibitor
eculizumab complement c5 biotech NA drugbank , DGIDB Paroxysmal nocturnal hemoglobinuria[MeSHID:D006457]
Atypical Hemolytic Uremic Syndrome[MeSHID:D065766]
Neuromyelitis Optica[MeSHID:D009471]
Hemolysis (disorder)[MeSHID:D006461]
Cardiac Arrest[MeSHID:D006323]
Thrombotic Microangiopathies[MeSHID:D057049]
Macular Degeneration
Age-Related
2[MeSHID:C562479]
Age related macular degeneration[MeSHID:D008268]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 45.47 approved,investigational antibody
eculizumab complement c5 biotech NA drugbank , DGIDB Paroxysmal nocturnal hemoglobinuria[MeSHID:D006457]
Atypical Hemolytic Uremic Syndrome[MeSHID:D065766]
Neuromyelitis Optica[MeSHID:D009471]
Hemolysis (disorder)[MeSHID:D006461]
Cardiac Arrest[MeSHID:D006323]
Thrombotic Microangiopathies[MeSHID:D057049]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 45.47 approved,investigational antibody
eculizumab complement c5 biotech NA drugbank , DGIDB Paroxysmal nocturnal hemoglobinuria[MeSHID:D006457]
Atypical Hemolytic Uremic Syndrome[MeSHID:D065766]
Neuromyelitis Optica[MeSHID:D009471]
Hemolysis (disorder)[MeSHID:D006461]
Cardiac Arrest[MeSHID:D006323]
Thrombotic Microangiopathies[MeSHID:D057049]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 45.47 approved,investigational antibody,inhibitor
click here to return to the previous page